Cargando…
Effect of Lenvatinib on a Hepatocellular Carcinoma with Fibroblast Growth Factor Receptor 4 Expression: A Case Report and Review of the Literature
Basic and clinical research have shown that the expression of molecules involved in the hepatocellular carcinoma (HCC) cell signaling pathway is related to the sensitivity to molecular-targeted agents. We herein report a case of HCC that was effectively treated with lenvatinib after a poor response...
Autores principales: | Shibata, Osamu, Kamimura, Kenya, Ko, Masayoshi, Sakai, Norihiro, Abe, Hiroyuki, Morita, Shinichi, Mizusawa, Takeshi, Sato, Hiroki, Sakamaki, Akira, Terai, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222122/ https://www.ncbi.nlm.nih.gov/pubmed/33390501 http://dx.doi.org/10.2169/internalmedicine.6580-20 |
Ejemplares similares
-
Effects of Atezolizumab and Bevacizumab on Adrenal Gland Metastasis of Hepatocellular Carcinoma: A Case Report and Review of Literature
por: Ishikawa, Natsuki, et al.
Publicado: (2022) -
HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma
por: Oda, Chiyumi, et al.
Publicado: (2022) -
Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021) -
Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023) -
Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A
por: Owaki, Takashi, et al.
Publicado: (2022)